Legend Biotech (LEGN) Current Leases (2019 - 2022)

Legend Biotech (LEGN) has 8 years of Current Leases data on file, last reported at $11.2 million in Q1 2026.

• Quarterly Current Leases rose 109.7% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (up 109.7% YoY) and the FY2025 annual result came in at $7.4 million, up 54.17% from the prior year.
• Current Leases advanced to $11.2 million in Q1 2026, from $7.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $11.2 million in Q1 2026 to a low of $2.9 million in Q3 2023.
• A 5-year average of $5.0 million and a median of $4.3 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases jumped 218070.95% — and 2024, when it sank 32.19%.
• Tracing LEGN's Current Leases over 5 years: stood at $3.6 million in 2022, then retreated by 10.89% to $3.2 million in 2023, then surged by 51.18% to $4.8 million in 2024, then surged by 54.17% to $7.4 million in 2025, then surged by 51.35% to $11.2 million in 2026.
• The last three Current Leases figures came in at $11.2 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.